Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency
NCT02112994
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Lysosomal Acid Lipase Deficiency
Interventions
DRUG:
Sebelipase Alfa
Sponsor
Alexion Pharmaceuticals, Inc.